About the Company
PharmEasy is India’s leading digital healthcare platform. It provides information, consultations, diagnostics tests, medicines, healthcare products and services from registered and trusted pharmacies, leading diagnostic laboratories and trusted doctors across India, serving every habitable zip code of the country.
The journey of PharmEasy was started in 2015, when founders Dharmil Sheth, an MBA from IMT Ghaziabad and Dr Dhaval Shah, MBBS from Rajiv Gandhi Medical College and MBA from XLRI Jamshedpur, came up with the idea of an online pharmacy to make healthcare affordable and accessible to one and all.
Overview of PharmEasy
They are India’s largest digital healthcare platform (based on GMV of products and services sold for the year ended March 31, 2021), according to RedSeer Report.
They operate an integrated, end-to-end business that aims to provide solutions for healthcare needs of consumers across the following critical stages
A. providing digital tools and information on illness and wellness.
B. offering Teleconsultation.
C. offering diagnostics and Radiology tests.
D. delivering treatment protocols including products and devices.
PharmEasy custom-built proprietary technology, unified data platforms, supply chain capabilities, and deep understanding of the dynamic interplay between the various sub-segments of India’s healthcare market are the capabilities that differentiate us.
These capabilities enable PharmEasy to provide each stakeholder in the healthcare value-chain, viz.:
(a) channel (wholesalers, retailers and chemists / institutions).
(b) consultants (and hospitals), diagnostic and radiology labs.
(d) companies (pharmaceutical, nutraceutical, medical devices).
The businesses have a presence across the country, with last-mile 163 capabilities to deliver in over 18,587 pin codes (for June 2021) via PharmEasy marketplace, allowing the ability to provide access in an affordable manner to the common man. The platforms have scaled across urban, semi-urban and rural India, with an ability to serve people across income groups and geographies.
Journey of PharmEasy
2015 – Started the journey in Mumbai and received angel funding.
2016 – Received Series-A funding and expanded into 5 cities. Same year they have started home-diagnostics service.
2017 – Received Series-B funding and expanded into 700 cities. Launched online delivery of health care products.
2018 – Received Series-C funding and expanded PAN India presence.
2019 – Received Series-D funding and expanded more than 22000+ PIN codes.
2020– It has got merged with Ascent Health and 5 other companies to form API Holdings, to form India’s biggest online healthcare company.
2021 – It has purchased 66% stakes in Thyrocare and this is the first listed company to be acquired by any Unicorn in India.
Currently, there is a team of 4000+ dedicated employees and have more than 10000+ retail stores working 24*7 to ensure medicines are delivered on time and at the best possible prices.
|March 2016||~34 Crores|
|March 2017||~104 Crores|
|April 2017||~13 Crores|
|February 2018||~13 Crores|
|September 2018||~350 Crores|
|September 2018||~2800 Crores|
|November 2019||~1650 Crores|
|April 2021||~2400 Crores|
|June 2021||~150 Crores|
Product and Services
If you check the website of PharmaEasy, you will find following services;
(i) Order Online Medicine
How it works?
Step-1: The buyer needs to upload the prescription. Once the PharmEasy receives it, they verify and send the same to the Medical stores near the pin code.
Step-2: PhameEasy delivery agent then collects medicine from Pharmacy and deliver to user.
(ii) Healthcare Products
Similar to buy medicine you can buy various healthcare products such as Nutritions, Personal care, Skin Care, Ayurvedic Products, Life-Style Ailments Products.
(iii) Diagnostics Tests
Under this service, you can book diagnostics test under PharmEasy labs. PharmeEasy labs is a diagnostic service offered by its partner lab Medlife Labs directly. Medlife is now being acquired by PharmEasy. As they have recently acquired Thyrocare, they are giving option to book test to these labs as well.
The business model is very simple and straight forward. It connects buyers, suppliers and distributors. Buyer has option to choose services such as Medicine, Health-Care Products, book diagnostic tests etc from the application and website.
They get 1-2% commission on selling medicines, they get advertisement money for displaying products of various pharmaceuticals, Nutraceuticals, companies etc. and also get income from diagnostics tests.
|Total Available Shares:||10000|
|Face Value:||₹ 1 Per Equity Share|
|Lot Size:||100 Shares|
|Current Unlisted Share Price:||₹ 115 Per Equity Share|
|Particulars (Fig. In Cr)||2016||2017||2018||2019||2020||2021||Jun-21|
|Revenue from Operation||0.14||33||111||358||667||2335||1100|
|Change in Inventory||-0.59||-9.82||-11||-42||-58||-114||-126|
|Employee Benefit Exps||4||14||38||80||137||270||165|
|Profit Before Tax||-11||-48||-101||-248||-347||-620||-319|
|Profit After Tax||-11||-48||-100||-243||-335||-641||-313|
Please find below the procedure for buying PharmEasy Unlisted Shares at UnlistedZone.
Please find below the procedure for selling PharmEasy Unlisted Shares at UnlistedZone.
Lock-in period of PharmEasy Unlisted Shares depends upon category of investors.
DIS - Delivery Instruction Slip is the way through which an investor can sell or transfer the PharmEasy Unlisted Shares from his/her demat account to any other demat account. There are two Types of DIS Slip.
In the last 4-5 years, the unlisted share market has become quite big and as a result of that, the ticket size has reduced from usual 5-10 Lac to 35-50k in today's scenario. So, via our UnlistedZone platform, if somebody wants to buy PharmEasy Unlisted Shares then minimum investment would be 35-50k.
Yes, buying and selling of unlisted shares in India is 100% legal.
If you sell your shares within 2 years, then you will have to pay Short-term Capital gain on unlisted shares. Short-Term Capital Gain is added in your Income. So, as per individual tax slab you need to pay capital gain tax.
If you sell your shares after 2 years, then you will have to pay Long-term Capital gain on unlisted shares LTCG is 20% with indexation benefits.
Taxes will remain the same irrespective of listing of shares, if bought in unlisted market. Actually, to be eligible for taxes as per listed market, one has to pay STT on buying and selling of shares. But, if you buy in unlisted and sell in listed market, one pay STT only on selling so, taxes of listed market will not be applicable
If you buy PharmEasy Unlisted Shares from UnlistedZone then these shares can checked in two ways. However, before we tell you the process of checking of shares, it is intimated that as per SEBI regulations, the shares can be transferred in demat account only.
Check credit of PharmEasy Unlisted Shares Instantly?
The PharmEasy Unlisted Shares are credited in demat account same day of transferring funds in our company's bank account.
The price of PharmEasy Unlisted Shares can be checked in two ways. First, you can join our telegram channel where on daily basis we share the latest prices of all the unlisted shares in the morning and secondly, you can register on UnlistedZone.live platform to see the historical graphs and prices of all the shares at one place.
If you see the thesis of investment in the unlisted shares then it is being done mainly to take the advantage of IPO market. And, if the IPO plans of company get delayed due to market conditions or any other reason then demand suddenly drops in the market. The unlisted market works mainly on demand and supply and if there is no IPO news then getting exit would be difficult.
"UnlistedZone is India's fastest and leading marketplace to buy and sell unlisted shares. In the last 3 years, we have already served more than 1 million users on the platform. The total transactions value done from the platform is already more than 100 Crores. The name of our Co-founders Mr. Umesh Paliwal and Dinesh Gupta publish regularly in leading newspapers like MoneyControl, Business-Standard, ET etc for their views on IPO and Unlisted market. In the last 3 years, UnlistedZone has made a good name for itself in the industry and gained a trust of their users. So, the new investors should not be worried about any kind of fraud that is mostly happens with unkown brokers in the market while doing investment with UnlistedZone."
We at UnlistedZone do the valuation based on 2 methods.
As an investor in the unlisted space, we would always recommend that you must check all the risk parameter carefully before investing in the unlisted space.
We source shares either from the employees or initial investors looking to liquidate their PharmEasy Unlisted Shares.
Pre-IPO shares means which are planning for an IPO in near future. So, all the shares which are traded on the platform are not Pre-IPO Shares. However, if the company's business is going good and then demand will always be there in the unlisted space, so even if the IPO does not come, the investors can easily liquidate their PharmEasy Unlisted Shares in the unlisted market itself.
Rules and regulations of SEBI are applicable in the Unlisted space like lock-in period of 6 months, paying of Stamp Duty, and DP Charges for every transaction etc. However, to become an unlisted broker there is no such regulation by SEBI as of yet.
For tracking news and other information about PharmEasy Unlisted Shares, one can visit our website wherein we post news and other information on daily basis and one can also join our telegram channel.